The website afm.nl uses cookies

Register Offering securities

This register contains (i) offer memorandums approved by the AFM pursuant to articles 5:74 and 5:76 of the Dutch Financial Supervision Act (Wet op het financieel toezicht, “FSA”) and (ii) announcements made either by the offeror or the offeree in relation to a public takeover offer.

The register implements the future obligation for the AFM to maintain a public register of offer memorandums approved by the AFM. This obligation is expected to be included in article 1:107 FSA and is likely to come into effect as per 1 July 2012.

 
 
 
 

Search results:

Publication dateOfferee companyOfferorTitle
12 jun 2013D.E. Master Blenders 1753 N.V.Joh. A. Benckiser-led Investor GroupUpdate on the intended offer by Oak Leaf for D.E MASTER BLENDERS 1753
06 jun 2013D.E. Master Blenders 1753 N.V.Joh. A. Benckiser-led Investor GroupUpdate on the intended offer by Oak Leaf for D.E MASTER BLENDERS 1753
10 mei 2013D.E. Master Blenders 1753 N.V.Joh. A. Benckiser-led Investor GroupUpdate intended offer by Joh. A. Benckiser-Ied investor group for D.E Master Blenders 1753
12 apr 2013D.E. Master Blenders 1753 N.V.Joh. A. Benckiser-led Investor GroupJoh. A. Benckiser-led investor group intends to make a recommended cash offer of €12.50 per ordinary share of D.E Master Blenders 1753
28 mrt 2013D.E. Master Blenders 1753 N.V.Joh. A. Benckiser-led Investor GroupD.E Master Blenders 1753 in negotiations with Joh. A. Benckiser on potential public offer for D.E. Master Blenders 1753
13 mrt 2013Dockwise Ltd.Koninklijke Boskalis Westminster N.V.Offer outcome: 99% of the Dockwise shares committed to Boskalis
07 mrt 2013Dockwise Ltd.Koninklijke Boskalis Westminster N.V.Dockwise applies for delisting from Euronext
28 feb 2013OctoPlus N.V.Dr. Reddy's Laboratories Ltd.Dr. Reddy’s holds 98.6% of the shares in OctoPlus N.V. after the Post Closing Acceptance Period
28 feb 2013OctoPlus N.V.Dr. Reddy's Laboratories Ltd.Dr. Reddy’s holds 98.6% of the shares in OctoPlus after the Post Closing Acceptance Period
26 feb 2013OctoPlus N.V.Dr. Reddy's Laboratories Ltd.Dr. Reddy’s acquires 48,065 shares in OctoPlus N.V.